Research Scientist
NCATS, NIH
Kellie received her PhD in Chemistry at Vanderbilt University under the mentorship of Prof. Craig Lindsley. She worked on developing allosteric modulators of several GPCRs, with the hopes of finding novel therapeutics for the treatment of schizophrenia, Alzheimer's disease, and diabetes. She then went on to a postdoc at the NCI-Frederick in the Chemical Biology Laboratory under Dr. Jordan Meier, working on RNA modifications, At NCATS, Kellie is an assay biologist in the Antiviral Program for Pandemics. She is excited to be a part of this group and work toward developing therapeutics for the current SARS-CoV-2 pandemic as well as pandemic potential viruses that may have no known treatments. In her free-time, Kellie enjoys playing board games, hiking, trying new restaurants, and hanging out at home with her partner and two cats.